These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 24794685)
1. Host natural killer immunity is a key indicator of permissiveness for donor cell engraftment in patients with severe combined immunodeficiency. Hassan A; Lee P; Maggina P; Xu JH; Moreira D; Slatter M; Nademi Z; Worth A; Adams S; Jones A; Cale C; Allwood Z; Rao K; Chiesa R; Amrolia P; Gaspar H; Davies EG; Veys P; Gennery A; Qasim W J Allergy Clin Immunol; 2014 Jun; 133(6):1660-6. PubMed ID: 24794685 [TBL] [Abstract][Full Text] [Related]
2. Relationship between patterns of engraftment in peripheral blood and immune reconstitution after allogeneic bone marrow transplantation for (severe) combined immunodeficiency. van Leeuwen JE; van Tol MJ; Joosten AM; Schellekens PT; van den Bergh RL; Waaijer JL; Oudeman-Gruber NJ; van der Weijden-Ragas CP; Roos MT; Gerritsen EJ Blood; 1994 Dec; 84(11):3936-47. PubMed ID: 7949150 [TBL] [Abstract][Full Text] [Related]
3. Neonatal bone marrow transplantation of ADA-deficient SCID mice results in immunologic reconstitution despite low levels of engraftment and an absence of selective donor T lymphoid expansion. Carbonaro DA; Jin X; Cotoi D; Mi T; Yu XJ; Skelton DC; Dorey F; Kellems RE; Blackburn MR; Kohn DB Blood; 2008 Jun; 111(12):5745-54. PubMed ID: 18356486 [TBL] [Abstract][Full Text] [Related]
4. Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT. Heimall J; Puck J; Buckley R; Fleisher TA; Gennery AR; Neven B; Slatter M; Haddad E; Notarangelo LD; Baker KS; Dietz AC; Duncan C; Pulsipher MA; Cowan MJ Biol Blood Marrow Transplant; 2017 Mar; 23(3):379-387. PubMed ID: 28068510 [TBL] [Abstract][Full Text] [Related]
5. Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency. Dvorak CC; Hassan A; Slatter MA; Hönig M; Lankester AC; Buckley RH; Pulsipher MA; Davis JH; Güngör T; Gabriel M; Bleesing JH; Bunin N; Sedlacek P; Connelly JA; Crawford DF; Notarangelo LD; Pai SY; Hassid J; Veys P; Gennery AR; Cowan MJ J Allergy Clin Immunol; 2014 Oct; 134(4):935-943.e15. PubMed ID: 25109802 [TBL] [Abstract][Full Text] [Related]
6. The effect of natural killer cell killer Ig-like receptor alloreactivity on the outcome of bone marrow stem cell transplantation for severe combined immunodeficiency (SCID). Keller MD; Chen DF; Condron SA; Liu N; Reinsmoen NL; Buckley RH J Clin Immunol; 2007 Jan; 27(1):109-16. PubMed ID: 17191149 [TBL] [Abstract][Full Text] [Related]
7. Competition within the early B-cell compartment conditions B-cell reconstitution after hematopoietic stem cell transplantation in nonirradiated recipients. Liu A; Vosshenrich CA; Lagresle-Peyrou C; Malassis-Seris M; Hue C; Fischer A; Di Santo JP; Cavazzana-Calvo M Blood; 2006 Aug; 108(4):1123-8. PubMed ID: 16614244 [TBL] [Abstract][Full Text] [Related]
8. Minimal dose of hematopoietic stem cell transplantation without myelosuppressive conditioning for T-B+NK- severe combined immunodeficiency. Yi ES; Ju HY; Cho HW; Lee JW; Sung KW; Koo HH; Kang ES; Ahn KM; Kim YJ; Yoo KH Clin Immunol; 2023 Mar; 248():109269. PubMed ID: 36804471 [TBL] [Abstract][Full Text] [Related]
9. Umbilical cord blood transplantation in severe T-cell immunodeficiency disorders: two-year experience. Knutsen AP; Wall DA J Clin Immunol; 2000 Nov; 20(6):466-76. PubMed ID: 11202237 [TBL] [Abstract][Full Text] [Related]
10. Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency. Hassan A; Booth C; Brightwell A; Allwood Z; Veys P; Rao K; Hönig M; Friedrich W; Gennery A; Slatter M; Bredius R; Finocchi A; Cancrini C; Aiuti A; Porta F; Lanfranchi A; Ridella M; Steward C; Filipovich A; Marsh R; Bordon V; Al-Muhsen S; Al-Mousa H; Alsum Z; Al-Dhekri H; Al Ghonaium A; Speckmann C; Fischer A; Mahlaoui N; Nichols KE; Grunebaum E; Al Zahrani D; Roifman CM; Boelens J; Davies EG; Cavazzana-Calvo M; Notarangelo L; Gaspar HB; Blood; 2012 Oct; 120(17):3615-24; quiz 3626. PubMed ID: 22791287 [TBL] [Abstract][Full Text] [Related]
11. Infusion of Host-Derived Unlicensed NK Cells Improves Donor Engraftment in Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation. Alvarez M; Pierini A; Simonetta F; Baker J; Maas-Bauer K; Hirai T; Negrin RS Front Immunol; 2020; 11():614250. PubMed ID: 33488624 [TBL] [Abstract][Full Text] [Related]
12. T cell and B Cell immunity can be reconstituted with mismatched hematopoietic stem cell transplantation without alkylator therapy in artemis-deficient mice using anti-natural killer cell antibody and photochemically treated sensitized donor T cells. Xiao TZ; Singh K; Dunn E; Ramachandran R; Cowan MJ Biol Blood Marrow Transplant; 2012 Feb; 18(2):200-9. PubMed ID: 22015994 [TBL] [Abstract][Full Text] [Related]